MetaCap

CollPlant Biotechnologies Insider Trades

NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD

3.13-0.08 (-2.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

CollPlant Biotechnologies insider activity

Over the last 12 months, CollPlant Biotechnologies insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Rotem Eran (Deputy CEO and CFO) reporting a transaction in 510,372 shares on Sep 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OPHI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

OPHI insider transactions

CollPlant Biotechnologies insider transactions
DateInsiderTypeSharesValueFiling
Sep 3, 2026Abelis Bar BertaVP LegalAward201,141—Form 4
Sep 3, 2026Rotem EranDeputy CEO and CFOAward510,372—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related